---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-088482"
form_type: "8-K"
ticker: "FDMT"
cik: "0001650648"
company_name: "4D Molecular Therapeutics, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:30:53.959705+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# 4D Molecular Therapeutics annual meeting results: all four proposals approved

## Summary
- Stockholders elected Jacob Chacko, Susannah Gray, and Charles Theuer as Class II directors.
- Ratified PricewaterhouseCoopers as independent auditor for FY2025.
- Say-on-pay proposal approved (31.8M for, 394k against, 35k abstain, 6.2M broker non-votes).
- Advisory vote on future say-on-pay frequency: one year chosen; company will hold annual votes.

## SEC filing metadata
- accession: 0000950170-25-088482
- form_type: 8-K
- ticker: FDMT
- cik: 0001650648
- company_name: 4D Molecular Therapeutics, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650648/000095017025088482/0000950170-25-088482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650648/000095017025088482/fdmt-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-088482
- JSON: https://secwatch.observer/filing/0000950170-25-088482.json
- Plain text: https://secwatch.observer/filing/0000950170-25-088482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.